TRUKING TECHNOLOGY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.48 CNY | -1.05% |
|
-5.46% | -20.75% |
| Sales 2023 * | 7.16B 988M | Sales 2024 * | 8.63B 1.19B | Capitalization | 5.01B 691M |
|---|---|---|---|---|---|
| Net income 2023 * | 524M 72.38M | Net income 2024 * | 680M 93.92M | EV / Sales 2023 * | 0.7 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.58 x |
| P/E ratio 2023 * |
8.74
x | P/E ratio 2024 * |
7.33
x | Employees | - |
| Yield 2023 * |
0.64% | Yield 2024 * |
1.46% | Free-Float | 53.93% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.05% | ||
| 1 week | -5.46% | ||
| Current month | -9.79% | ||
| 1 month | -17.19% | ||
| 3 months | -11.76% | ||
| 6 months | -29.04% | ||
| Current year | -20.75% |
1 week
8.20
8.97
1 month
8.2010.26
Current year
6.9110.80
1 year
6.9116.96
3 years
6.9129.94
5 years
6.1629.94
10 years
6.1645.63
| Managers | Title | Age | Since |
|---|---|---|---|
Yue Tang
CEO | Chief Executive Officer | 60 | 10-10-24 |
Yun Hong Xiao
DFI | Director of Finance/CFO | 48 | 16-11-14 |
Gui Lin Liu
CHM | Chairman | 59 | 09-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shan Ping Wang
BRD | Director/Board Member | 60 | 22-05-12 |
Yue Tang
CEO | Chief Executive Officer | 60 | 10-10-24 |
Wen Lu Yang
BRD | Director/Board Member | 62 | 10-10-24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +0.89% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 8.48 | -1.05% | 4 307 299 |
| 24-04-18 | 8.57 | -1.49% | 5,681,200 |
| 24-04-17 | 8.7 | +6.10% | 6,665,263 |
| 24-04-16 | 8.2 | -5.20% | 7,818,808 |
| 24-04-15 | 8.65 | -1.59% | 7,137,743 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
TRUKING TECHNOLOGY LIMITED is a China-based company engaged in the research, development, manufacture and sale of pharmaceutical equipment for liquid categories. The Company mainly provides pharmaceutical equipment for liquid categories, which are used for producing of small volume ampoule, vial, powder injection, oral liquid and large volume infusion and others. The Company's products include ampoule compact lines, vial compact lines, oral liquid compact lines and infusion bottle compact lines. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-04-24
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.48
CNY
Average target price
19.25
CNY
Spread / Average Target
+127.00%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.75% | 699M | |
| -1.91% | 14.82B | |
| +32.51% | 5.28B | |
| -10.98% | 4.99B | |
| -3.91% | 4.92B | |
| -12.49% | 4.34B | |
| +9.84% | 4.17B | |
| +21.18% | 3.9B | |
| +36.62% | 3.68B | |
| +0.40% | 3.33B |
- Stock Market
- Equities
- 300358 Stock
